What is BPC-157?
A synthetic pentadecapeptide derived from a sequence present in human gastric juice protein. Laboratory literature examines mucosal, vascular, and connective-tissue models.
Research use only. Not for human or veterinary use.
BPC-157
10 MG
Overview
BPC-157 is a fifteen-amino-acid peptide first isolated as a fragment of a protective protein found in gastric juice. In published preclinical work it has been used as a defined reagent in models of gastrointestinal mucosa, tendon and ligament explants, and endothelial signaling. Vybe supplies this material as a lyophilized laboratory reagent with lot-matched analytical documentation. The research record is dominated by animal and in-vitro studies; it is not an approved drug and is not sold for human or veterinary use.
Research areas
Framed as published laboratory and clinical literature. Not treatment guidance.
Gastrointestinal mucosa models
Early papers described effects on experimental gastric and intestinal lesions in rodents, including measures of mucosal integrity and angiogenesis-related markers. These studies are experimental, not clinical treatment protocols.
Connective-tissue explants
Independent groups have applied BPC-157 in tendon, ligament, and muscle injury models, reporting changes in collagen organization, nitric-oxide related signaling, and functional recovery scores in animals.
Vascular and endothelial assays
In-vitro and in-vivo work has examined endothelial cell outgrowth, nitric-oxide synthase pathways, and vessel density after experimental injury. Findings remain confined to laboratory systems.
Published research
A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine
Biological Psychiatry · 1998
PMID 9513744 · DOI 10.1016/s0006-3223(97)00277-1
Open sourcePentadecapeptide BPC 157 and the central nervous system
Current Neuropharmacology · 2022
PMID 34365958 · PMCID PMC9881108 · DOI 10.2174/1570159X19666210809130954
Open sourceStable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Current Pharmaceutical Design · 2011
PMID 21548867 · DOI 10.2174/138161211795703735
Open source
Storage & handling
Lyophilized powder. Store at −20 °C, desiccated and protected from light. Ships at ambient temperature; transfer to −20 °C on receipt.
Frequently asked questions
What is BPC-157?
A synthetic 15-amino-acid peptide related to a sequence in human gastric juice protein. It is supplied here as a laboratory research reagent only.
What is its CAS number?
137525-51-0.
What areas has it been studied in?
Published work includes gastrointestinal mucosa, connective-tissue, and endothelial models, almost entirely in animals or cell culture.
How should lyophilized material be stored?
Keep the sealed vial desiccated and protected from light, following the storage line on the lot paperwork. Do not treat this as a use instruction for people or animals.
Where can I view published research?
The PubMed and PMC links on this page open the original papers. Vybe is not the scientific publisher.
Is this sold for human use?
No. Vybe Aminos products are laboratory research materials, not for human or veterinary use, and this page is not medical advice.
Key facts
- Full name
- Body protection compound-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val)
- Common name
- BPC-157
- CAS number
- 137525-51-0
- Molecular formula
- C62H98N16O22
- Molecular weight
- 1419.54
- Research category
- Tissue Repair
- Form
- Lyophilized powder
- Storage
- Lyophilized powder. Store at −20 °C, desiccated and protected from light. Ships at ambient temperature; transfer to −20 °C on receipt.
- Available sizes
- 10mg, 20mg